Statistics from Altmetric.com
Q In persons with impaired glucose tolerance, does an intensive lifestyle intervention (ILS) or treatment with metformin plus standard lifestyle recommendations prevent onset or promote resolution of metabolic syndrome?
Clinical impact ratings GP/FP/Primary care ★★★★★★☆ IM/Ambulatory care ★★★★★☆☆ Endocrine ★★★★☆☆☆
randomised placebo controlled trial (The Diabetes Prevention Program randomised trial).
blinded (clinicians, participants, data collectors, and outcome assessors for metformin and placebo).*
mean 3.2 years.
27 centres in the US.
3234 participants ⩾25 years of age (mean age 51y, 68% women) without diabetes who had a body mass index ⩾24 kg/m2 (⩾22 kg/m2 for Asian Americans) and a plasma glucose concentration 5.3–7.0 mmol/l (95–125 mg/dl) (⩽7.0 mmol/l [⩽125 mg/dl] for Native Americans) …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.